Aim: Heart transplantation is currently considered the optimal surgical approach for treatment of refractory heart failure, as it offers a higher likelihood survival well significant improvements to quality life. We aim identify factors that relate post-transplantation among patients who received cardiac transplantation. Material and Methods: retrospectively included all transplant recipients u...

Heart transplantation is an accepted therapeutic modality for end-stage congenital heart disease for both biventricular and univentricular anomalies. Many transplant centers have pushed the limits of transplantation to include patients with high pulmonary vascular resistance, high panel reactive antibodies, positive cross-matches, and ABO-incompatibility. Excellent results have been possible, p...

BACKGROUND Cardiorenal syndrome has been recently divided into 5 categories, according to acute or chronic evolution and primary organ dysfunction. Anemia can also accompany this disorder, leading to a more complex situation. This study aims to analyze the renal outcomes of patients, specifically patients with chronic Cardiorenal syndrome, with or without anemia, long-term after heart transplan...

edical and electrical therapies for systolic heart failure have improved patients’ outcome and the altered natural history of the disease. Although heart transplantation remains the most successful treatment option for patients with advanced heart failure refractory in terms of medical and electrical treatments, cardiac transplantation is available for only a minority of patients because of a l...

Altered sympathetic activity and peripheral vascular function are suspected as a mechanism of the development of arterial hypertension in organ transplantation recipients treated with cyclosporine. We assessed whether cyclosporine might alter peripheral vascular properties or autonomic modulation of the sinus node and the vasculature during rest and standing. We examined 17 orthotopic heart tra...

Heart transplantation is without doubt a very effective treatment for patients’ whose lives and wellbeing are threatened by their failing heart. We previously categorized our concerns into four areas or Ds: Donor availability, Disorganization, Disillusionment (of clinicians) and Disaffection (of tomorrow’s clinicians). After a decade, this is a timely reflection on this crisis of cardiac transp...

OBJECTIVE To determine the outcome of heart transplantation for end stage amyloid heart disease in patients treated at a single centre. DESIGN Records of all patients with amyloid heart disease who underwent heart transplantation were examined to determine survival, graft involvement by amyloid, the course of systemic amyloid disease, and the cause of death. PATIENTS 10 patients, mean (SD) ...

With the advances in congenital cardiac surgery and postoperative care, an increasing number of children with complex congenital heart disease now reach adulthood. There are already more adults than children living with a congenital heart defect, including patients with complex congenital heart defects. Among these adults with congenital heart disease, a significant number will develop ventricu...

Cardiac transplantation has become limited by a critical shortage of suitable organs from brain-dead donors. Reports describing the successful clinical transplantation of hearts donated after circulatory death (DCD) have recently emerged. Hearts from DCD donors suffer significant ischemic injury prior to organ procurement; therefore, the traditional approach to the transplantation of hearts fro...

conclusions the hormonal levels were low in patients with idiopathic dilated cardiomyopathy. however, the prognostic significance of different hormonal deficiencies was not clear in our study populations who were receiving standard therapies for heart failure and had a relatively stable clinical condition. results except for testosterone level, the levels of gh, igf-1, t3, and t4 concentrations...